Home › Compare › PFFOF vs ABBV
PFFOF yields 32786.89% · ABBV yields 3.06%● Live data
📍 PFFOF pulled ahead of the other in Year 1
Combined, PFFOF + ABBV cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of PFFOF + ABBV for your $10,000?
Portofino Resources Inc. acquires, explores for, and develops mineral properties in the Americas. The company holds an option to acquire 100% interests in the Sapawe West property that comprises 3 claims totaling 1,147 hectares located in the Schwenger and McCaul Townships, Ontario; the Gold Creek property comprising 15 mining claims containing 197 contiguous cell units covering an area of approximately 4,036 hectares located primarily in the Duckworth Township, Ontario; and the Melema West gold property covering an area of 869 hectares located to the northeast of the town of Atikokan, Ontario. It also holds an option to acquire 100% interest in the South of Otter project covering an area of 5,363 hectares located to the southeast of the town of Red Lake, Ontario. In addition, the company has option assignment agreement to acquire a 100% interest in the Bruce Lake property that comprises 5 mineral claims totaling 1,428 hectares located in the Red lake, Ontario; the Allison Lake North property comprises 4 claims totaling 1,618 hectares located to the east of the Red Lake in northwestern Ontario; the Allison Lake North Birkett and Costello Lake property located in northwestern Ontario; holds a 100% interest in the Greenheart Lake property comprises 3 claims totaling approximately 1,200 hectares; and McNamara lithium property comprises 3 claims totaling approximately 1,120 hectares located in northwestern, Ontario. The company was formerly known as Crude Investments Corp. and changed its name to Portofino Resources Inc. in March 2012. Portofino Resources Inc. was incorporated in 2011 and is headquartered in Vancouver, Canada.
Full PFFOF Calculator →AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; Lupron for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; and Botox therapeutic. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist for women with moderate to severe endometriosis pain; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; Lumigan/Ganfort, a bimatoprost ophthalmic solution for the reduction of elevated intraocular pressure (IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Ubrelvy to treat migraine with or without aura in adults; Alphagan/ Combigan, an alpha-adrenergic receptor agonist for the reduction of IOP in patients with OAG; and Restasis, a calcineurin inhibitor immunosuppressant to increase tear production, as well as other eye care products. AbbVie Inc. has a research collaboration with Dragonfly Therapeutics, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
Full ABBV Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.